Ariad Pharma

Before Iclusig safety flaws went public, ex-Ariad staffer told family to sell shares: feds
Fierce Pharma
Wed, 06/28/17 - 10:46 pm
Iclusig
Ariad Pharma
insider trading
Japan's Takeda ready for fresh acquisitions after $5.2 bln Ariad deal
Yahoo/Reuters
Wed, 01/11/17 - 09:55 am
Takeda
Ariad Pharma
M&A
Monday’s 4 Biggest Biopharma Movers
Yahoo/24-7 Wall St
Mon, 01/9/17 - 06:39 pm
Ariad Pharma
Arrowhead
Alcobra
Merrimack Pharmaceuticals
Ariad's Iclusig Gets FDA OK and Label Update
Investopedia
Wed, 11/30/16 - 10:36 pm
Ariad Pharma
Iclusig
FDA
chronic myeloid leukemia
Ph+ ALL
Ariad reports 3Q loss
Yahoo/AP
Mon, 11/7/16 - 09:39 am
Ariad Pharma
earnings
Ariad Pharma Rises on FDA Decision
Yahoo/24-7 Wall St
Mon, 10/31/16 - 09:37 am
Ariad Pharma
FDA
brigatinib
non-small cell lung cancer
What's the next pricing uproar? Ariad, Novum and Lannett could be candidates
Fierce Pharma
Fri, 10/7/16 - 04:52 pm
drug pricing
Ariad Pharma
Novum
Lannett
Ariad appears on the upswing as investors renew hopes of a buyout
Bizjournals.com
Sat, 05/7/16 - 01:09 pm
Ariad Pharma
brigatinib
M&A
Ariad’s new CEO appears focused on cost cuts in first call with investors
Bizjournals.com
Wed, 02/24/16 - 04:45 pm
Ariad Pharma
Pharma CEOs
Paris Panayiotopoulos
Ariad preps for a sale, but new chairman says it may take time
Bizjournals.com
Tue, 01/19/16 - 08:24 am
Ariad Pharma
M&A
EMD Serono president named Ariad's new CEO
Bizjournals.com
Fri, 12/18/15 - 09:00 am
EMD Serono
Ariad Pharma
Harvey Berger
Report: Baxalta's $2B plot to buy Ariad broke down over price
Fierce Biotech
Wed, 09/2/15 - 05:13 pm
Baxalta
Ariad Pharma
M&A
Baxalta may have a new M&A-based strategy for spurning Shire
BioPharma Dive
Tue, 09/1/15 - 06:45 pm
Shire
Baxalta
M&A
Ariad Pharma
Ariad and Baxalta stay mum on merger reports, but speculation abounds
Bizjournals.com
Mon, 08/31/15 - 05:33 pm
Ariad Pharma
Baxalta
M&A
Activist Hedge Fund Seeks Firing of Ariad Pharma CEO Berger
TheStreet.com
Fri, 02/20/15 - 10:04 am
Ariad Pharma
Pharma CEOs
Harvey Berger
The Worst Biotech CEO of 2013 Is...
TheStreet.com
Tue, 12/17/13 - 08:48 am
biotech
Vical
Ariad Pharma
Aveo Oncology
Dendreon
Amarin
Down 20%: Ariad Pharmaceuticals' Second Dose of Bad News
Motley Fool
Sat, 10/12/13 - 10:34 am
Ariad Pharma
Synta Pharma: Poised For A Breakout With 4 Near-Term Catalysts
Seeking Alpha
Thu, 12/13/12 - 04:23 pm
Synta Pharmaceuticals
Ariad Pharma
GSK
Bristol-Myers Squibb
FDA Rejection. EU Withdrawal. Set and Match?
Motley Fool
Fri, 11/30/12 - 09:39 am
FDA
Europe
ridaforolimus
Ariad Pharma
Merck
FDA Agrees to Speed Review of Ariad Drug
Motley Fool
Fri, 10/26/12 - 11:15 am
FDA
Ariad Pharma
Ponatinib
chronic myeloid leukemia
acute lymphoblastic leukemia

Pages